MedPath

BLADDER CANCER SCREENING AMONG DIABETIC PATIENTS

Early Phase 1
Completed
Conditions
Diabetes
Bladder Cancer
Registration Number
NCT02505516
Lead Sponsor
UFUOMA MILLER FAKPOR
Brief Summary

patients om metformin from diabetic clinic were checked for bladder cancer

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria
  • 150 people attending diabetic clinic
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Number of diabetic patients on metformin therapy6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Universty of Capecoast

🇬🇭

Cape Coast, Ghana

Universty of Capecoast
🇬🇭Cape Coast, Ghana

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.